Abstract
Cardiogenic shock is severe, refractory heart failure caused by significant myocardial dysfunction in the setting of adequate preload that is accompanied by systemic hypoperfusion. Progressive end-organ dysfunction is a hallmark of persistent cardiogenic shock and necessitates intervention to overcome altered hemodynamics and restore end-organ perfusion. Temporary percutaneous mechanical circulatory support is an established modality in the treatment of cardiogenic shock and is increasingly used in patients with cardiogenic shock as a bridge to recovery or further definitive therapy. This article reviews the current devices, their effects on left ventricular hemodynamics, and the evidence supporting their continued use.
Original language | English (US) |
---|---|
Pages (from-to) | 385-398 |
Number of pages | 14 |
Journal | Heart Failure Clinics |
Volume | 12 |
Issue number | 3 |
DOIs | |
State | Published - Jul 1 2016 |
Keywords
- Cardiogenic shock
- ECMO
- IABP
- Impella
- Percutaneous mechanical circulatory support
- Pressure-volume loop
- TandemHeart
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine